Breaking GOP Candidates Navigate Trump Association Ahead of Midterms Four Killed in Small Plane Crash Near Seldovia, Alaska Gang Attack in Kenscoff, Haiti, Leaves Dozens Dead and Kidnapped Communication Issues Cited in Ronald Reagan Airport Incident Former President Trump to Visit Ireland Amid Anticipated Protests

Thursday August 27, 2026

Reporter

Celcuity Inc.

4Articles Published

4Communities Covered

Published Articles

Press Release

Celcuity Submits sNDA to FDA for REVTORPYK™ (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer

Aug 26

Press Release

Celcuity Inc. Reports Release of Second Quarter 2026 Financial Results and Provides Corporate Update

Aug 17

Press Release

Celcuity Schedules Release of Second Quarter 2026 Financial Results and Webcast/Conference Call

Aug 6

Press Release

Newly FDA-Approved REVTORPYK™ (gedatolisib) Included in the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines for HR+/HER2- Locally Advanced or Metastatic Breast Cancer

Jul 30